Thieler Law Corp advises investors with losses exceeding $100,000 of the August 8, 2016 lead plaintiff deadline in a class action lawsuit filed against Immunomedics Inc (NASDAQ:IMMU) (“Immunomedics” or “the Company”). The suit is pending in the U.S. District Court for the District of New Jersey and investors, who purchased Immunomedics Inc securities between April 20, 2016 and June 2, 2016, have until August 8, 2016 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Immunomedics Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that Immunomedics’ abstract for IMMU-132 submitted to the American Society of Clinical Oncology (“ASCO”) for presentation at the 2016 ASCO Annual Meeting contained previously disclosed results from a mid-stage study; Immunomedics misrepresented to ASCO that its abstract for IMMU-132 contained only updated and previously undisclosed data; the foregoing misrepresentation was a violation of ASCO policy and made Immunomedics’ IMMU-132 presentation subject to removal from the 2016 ASCO Annual Meeting schedule; and as a result, Immunomedics’ public statements were materially false and misleading at all relevant times.

On a June 2, 2016, media revealed that the American Society of Clinical Oncology had removed a scheduled presentation by Immunomedics regarding the Company's IMMU-132 breast cancer drug from American Society of Clinical Oncology's annual meeting.

Following this news, the Company stock dropped more than $0.80, or 15%, to $4.49 pre-market on June 3, 2016.

If you were negatively impacted by your investment in Immunomedics Inc securities between April 20, 2016 and June 2, 2016 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185